Affiliation:
1. Pramukhswami Medical College, Anand, Gujarat, India
Abstract
: Multidrug-resistant organisms (MDROs) has become a major public health concern. Rise of MDROs and their negative consequences on patient’s survival and health care costs need the assessment of their burden and implementation of practices to control their emergence and spread. There is a lack of literature mentioning incidence density rates (IDR) of various MDRO infections in Indian hospitals. Therefore, the study was conducted to determine the infection IDR and trend of various MDROs at a tertiary care teaching hospital. It will serve as a benchmark data for similar facilities using the same surveillance definitions and methodology. : A retrospective cross-sectional study was conducted using culture data of ten years (January 2014 to December 2023) at Shree Krishna Hospital, Karamsad. MDRO studied included Methicillin-resistant (MRSA), V (VRE), (CRE), Multidrug-resistant (MDR) spp. and MDR . A total of 7311 MDRO were detected from 1321793 in-patients, showing the overall IDR of 5.53 per 1000 patients-days. CRE (n = 3056, 42%) was the most common MDRO. The overall IDR per 1000 patient-days of MRSA, VRE, CRE, MDR- ., and MDR- was 0.81, 0.23, 2.31, 1.29 and 0.89 respectively. Overall MDRO IDR has increased from 4.20 to 8.77 from 2014 to 2023. An increasing IDR was observed for MRSA (0.57 to 1.48) and MDR- (0.43 to 1.60). Around 80% of the . were MDR as compared to other MDRO. MDROs have been identified as a significant problem at our institute showing an increasing trend. We recommend following stringent infection control practices including isolation protocols as well as adherence to hospital antibiotic policy to reduce the burden of MDROs.
Publisher
IP Innovative Publication Pvt Ltd
Reference29 articles.
1. Anaya-Baz B, Maldonado N, Palaciosbaena ZR, Palomo V, Pezzani M Diletta, Chiesi S, Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol.BMJ Open 2020;10(5):e030608
2. Wattal C, Goel N, Oberoi JK, Raveendran R, Datta S, Prasad KJ, Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India.J Assoc Physicians India 2010;58:32-6
3. Gandra S, Tseng KK, Arora A, Bhowmik B, Robinson ML, Panigrahi B, The mortality burden of multidrug-resistant pathogens in India: a retrospective, observational study.Clin Infect Dis 2019;69(4):563-70
4. Kalluru S, Eggers S, Barker A, Shirley D, Sethi AK, Sengupta S, Risk factors for infection with multidrug-resistant organisms in Haryana, India.Am J Infect Control 2018;46(3):341-5
5. Rodríguez-Villodres Á, Martín-Gandul C, Peñalva G, Guisado-Gil AB, Crespo-Rivas JC, Pachón-Ibáñez ME, Prevalence and risk factors for multidrug-resistant organisms colonization in long-term care facilities around the world: a review.Antibiotics (Basel) 2021;10(6):680